Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Kioson Komersial Indonesia Tbk (KIOS) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Kioson Komersial Indonesia TbkTrade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Kioson Komersial Indonesia Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Kioson Komersial Indonesia Tbk trades at Rp99 (market cap 110.81B, 29.99M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is the larger of the two by market cap, and Kioson Komersial Indonesia Tbk is more actively traded (29.99M versus 324K). Which is the better fit depends on your goals.

KIOSOBAT
Market Cap
110.81B166.01B
Volume
29.99M324K
Lot
299.94K3.24K
Turnover
2.97B77.68M
Average Price
99239.75
Value
2.97B77.68M
Indicative Equilibrium Price
99240
Indicative Equilibrium Volume
3.34K1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

KIOS
View details
OBAT
View details

About Kioson Komersial Indonesia Tbk

PT Kioson Komersial Indonesia Tbk (the Company), was established on June 29, 2015 based on Notarial Deed No. 55 of Rose Takarina, S.H.

Read more on KIOS

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT